Schedule 13G ownership disclosure

IONIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 462222100

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,654,019
Percent of class
5.5600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000313
Form type
SC 13G/A
Filer
IONIS PHARMACEUTICALS INC
CIK
CIK 874015
Filed
Feb 12, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub